SEC Form 4 · accession 0001209191-15-082245

Enovis CORP · ENOV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Clay Kiefaber

Officer — ESAB Global CEO & EVP - Colfax

Period of report

Nov 23, 2015

Accepted (ET)

Nov 25, 2015 · 4:07 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001420800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, par value $.001	Nov 23, 2015	M	24,690	$11.85	A	120,457	D
Common Stock, par value $.001^F1	Nov 23, 2015	S	24,690	$27.042	D	95,767	D
Common Stock, par value $.001	Nov 24, 2015	M	54,424	$11.85	A	150,191	D
Common Stock, par value $.001	Nov 24, 2015	M	68,082	$12.27	A	218,273	D
Common Stock, par value $.001	Nov 24, 2015	M	51,677	$21.77	A	269,950	D
Common Stock, par value $.001^F2	Nov 24, 2015	S	174,183	$27.1165	D	95,767	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4,F3	$11.85	Nov 23, 2015	M	24,690	D	—	Mar 28, 2017	Common Stock, par value $.001	24,690	54,424	D
Employee Stock Option (right to buy)^F3	$11.85	Nov 24, 2015	M	54,424	D	—	Mar 28, 2017	Common Stock, par value $.001	54,424	0	D
Employee Stock Option (right to buy)^F6,F5	$12.27	Nov 24, 2015	M	68,082	D	—	Jan 10, 2017	Common Stock, par value $.001	68,082	0	D
Employee Stock Option (right to buy)^F7	$21.77	Nov 24, 2015	M	51,677	D	—	Feb 23, 2018	Common Stock, par value $.001	51,677	0	D

Explanation of responses

F1The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.15, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.355, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3The option vested in three equal annual installments beginning on March 29, 2011.
F4Mr. Kiefaber's pecuniary interest in 15,823 options in this tranche were previously transferred to his ex-wife pursuant to a domestic relations order.
F5The option vested in three equal annual installments beginning on January 11, 2011.
F6Mr. Kiefaber's pecuniary interest in 34,042 options in this tranche were previously transferred to his ex-wife pursuant to a domestic relations order.
F7The option vested in three equal annual installments beginning on February 24, 2012.